Ziyan Wang
Healthcare market access, commercialization, and policy strategist with nearly 20 years of experience across China and Asia-Pacific.
A Career Built Across Healthcare Systems
WHO
Geneva, Switzerland
↓
London School of Economics (LSE Health)
London, United Kingdom
↓
Johnson & Johnson
Belgium
↓
Eli Lilly & Company
Shanghai, China
↓
Bristol Myers Squibb
Shanghai, China
↓
Bracco
Shanghai, China
↓
LivaNova
Singapore | Asia-Pacific
↓
ACCESSBRIDGE Healthcare Advisory
Singapore
Experience spanning healthcare policy, reimbursement, funding, pricing, market access, and commercialization across global, regional, and local healthcare systems.
What Shaped My Perspective
Throughout my career, I have worked across healthcare policy, reimbursement, market access, pricing, and commercialization functions.
This experience taught me that healthcare success is rarely determined by a single application, stakeholder meeting, or commercial initiative.
The most successful organizations understand how healthcare policy, payer priorities, clinical practice, stakeholder incentives, and commercial objectives interact within the broader healthcare system.
This systems perspective continues to shape how I support clients today.
Areas of Expertise
Funding & Reimbursement
Market Access Strategy
Healthcare Policy
Commercialization
Go-to-Market Strategy
Stakeholder Engagement
China Market Entry
APAC Market Development
Author & Thought Leadership
Ziyan is co-author of Towards A Healthy China: The Institutional Logic and Strategic Pathways to a Pharmaceutical Powerhouse.
The book explores the interaction between healthcare systems, innovation, industrial policy, and national competitiveness, reflecting her long-standing interest in how healthcare policy and innovation can work together to improve patient access and healthcare outcomes.
Beyond Consulting
I founded ACCESSBRIDGE to help healthcare innovators navigate increasingly complex healthcare systems and make better strategic decisions before execution begins.
My goal is to help organizations transform complexity into clarity, enabling sustainable patient access and long-term commercial success.